Instrument number PB 19 of 2008
Amendment special arrangements under subsection 100(1) of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.
Dated 2nd January 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program
1 Commencement
This instrument commences on 1 February 2008.
2 Amendment of PB 93 of 2007
Schedule 1 amends PB 93 of 2007.
Schedule 1 Amendments
[1] Schedule 1, item dealing with Pemetrexed
omit from the column headed “Circumstances” the words:
Pleural mesothelioma
and substitute:
Mesothelioma
[2] Schedule 2, item dealing with Cetuximab
omit from the column headed “Maximum quantity”:
6
and substitute:
1
[3] Schedule 3, item dealing with Cetuximab
omit from the column headed “Maximum quantity”:
4
and substitute:
1
[4] Schedule 3, item dealing with Pemetrexed
omit from the column headed “Purposes” the words:
Pleural mesothelioma
and substitute:
Mesothelioma